glp 1 png GLP-1s Glucagon-like Peptide 1 Glp1 7-36

de Souza, A

However, a significant challenge in evaluating kidney outcomes lies in the inconsistent definitions of renal endpoints across studies, particularly regarding the thresholds for substantial eGFR decline, which vary from 30% to 57%

CGM-specific education should address device operation, data interpretation, insulin regimen optimization using Ambulatory Glucose Profile (AGP) data and glucose patterns, and trend arrows for insulin dosing adjustments

Because weight loss can occur alongside inadequate protein intake, muscle loss, vitamin deficiencies, mineral depletion, and anemia risk

All prescribing decisions, including custom dosing and titration protocols, must be made by a licensed clinician based on individual patient clinical need